Structures by: Sinha A. S.
Total: 89
CG-P2-L1-EtOAc N-(2-pyridylmethyl)-2,2-biimidazole
C12H11N5
Faraday Discuss. (2017)
a=21.5686(12)Å b=5.8077(3)Å c=18.0356(10)Å
α=90.00° β=110.1298(16)° γ=90.00°
CG-P2-A3-D7 [N-(4-pyridylmethyl)-2,2-biimidazole]2, 1,2-diiodotetrafluorobenzene
(C12H11N5)2(C6F4I2)
Faraday Discuss. (2017)
a=17.386(2)Å b=19.378(3)Å c=19.435(3)Å
α=92.996(5)° β=106.710(5)° γ=106.560(4)°
C18H21N5O4
C18H21N5O4
Faraday Discuss. (2017)
a=17.295(2)Å b=4.8014(7)Å c=21.977(3)Å
α=90° β=90.912(11)° γ=90°
C12H11N5
C12H11N5
Faraday Discuss. (2017)
a=5.493(2)Å b=10.339(4)Å c=10.611(4)Å
α=112.83(2)° β=99.24(3)° γ=94.16(3)°
C12H11N5,C7H6O2
C12H11N5,C7H6O2
Faraday Discuss. (2017)
a=6.42690(10)Å b=9.9656(2)Å c=13.5194(3)Å
α=96.6910(10)° β=95.6860(10)° γ=100.6030(10)°
CG-P1-A1-HBD1 N-(2-pyridylmethyl)-2,2-biimidazole, HOOC-(CH2)2-COOH
(C12H11N5)(C4H6O4)
Faraday Discuss. (2017)
a=5.0716(9)Å b=11.314(2)Å c=14.051(3)Å
α=90.818(7)° β=99.190(6)° γ=99.925(6)°
C12H12N5,C8H13O4
C12H12N5,C8H13O4
Faraday Discuss. (2017)
a=5.1948(2)Å b=10.8967(3)Å c=18.2317(6)Å
α=105.5790(10)° β=95.6070(10)° γ=100.1040(10)°
CG-P2-A2-D10 N-(3-pyridylmethyl)-2,2-biimidazole, 1,3,5-F3-2,4,6-I3-benzene
(C12H11N5)(C6F3I3)
Faraday Discuss. (2017)
a=16.0707(15)Å b=9.0666(8)Å c=14.8610(14)Å
α=90.00° β=107.218(3)° γ=90.00°
C12H11N5,C7H6O2
C12H11N5,C7H6O2
Faraday Discuss. (2017)
a=7.028(2)Å b=9.024(3)Å c=13.602(4)Å
α=90.229(19)° β=91.564(17)° γ=93.223(16)°
C12H11N5
C12H11N5
Faraday Discuss. (2017)
a=7.490(3)Å b=9.841(4)Å c=15.253(5)Å
α=90° β=99.072(17)° γ=90°
C12H11N5,0.5(C6F4I2)
C12H11N5,0.5(C6F4I2)
Faraday Discuss. (2017)
a=5.4649(17)Å b=11.660(4)Å c=12.493(4)Å
α=84.163(17)° β=80.913(13)° γ=76.728(13)°
CG-P2-A2-HBD2 [N-(3-pyridylmethyl)-2,2-biimidazole]2, HOOC-(CH2)4-COOH
(C12H11N5)2(C6H10O4)
Faraday Discuss. (2017)
a=8.0078(17)Å b=10.167(2)Å c=18.969(4)Å
α=79.276(6)° β=82.529(5)° γ=70.640(5)°
C12H11N5,0.5(C12H22O4)
C12H11N5,0.5(C12H22O4)
Faraday Discuss. (2017)
a=5.2936(3)Å b=7.9437(5)Å c=22.8847(13)Å
α=81.583(5)° β=85.500(6)° γ=70.615(5)°
CG-P2-A2-HBD2 [N-(3-pyridylmethyl)-2,2-biimidazole]2, HOOC-(CH2)8-COOH
(C12H11N5)2(C10H18O4)
Faraday Discuss. (2017)
a=5.7402(10)Å b=9.3514(16)Å c=14.973(3)Å
α=97.467(5)° β=91.771(6)° γ=97.861(5)°
CG-P2-A3-HBD1 N-(4-pyridylmethyl)-2,2-biimidazole, HOOC-(CH2)2-COOH
(C12H11N5)(C4H6O4)
Faraday Discuss. (2017)
a=4.8081(7)Å b=11.0210(17)Å c=14.819(2)Å
α=97.881(6)° β=91.543(6)° γ=90.181(6)°
CG-P2-A3-D9 [N-(4-pyridylmethyl)-2,2-biimidazole]2, 1,4-diiodotetrafluorobenzene
(C12H11N5)2(C6F4I2)(C1H4O)
Faraday Discuss. (2017)
a=13.4945(9)Å b=14.8017(10)Å c=19.3714(13)Å
α=111.285(2)° β=92.518(2)° γ=112.668(2)°
Sinapic Acid + 4-Pyridinecarbonitrile
C11H12O5,C6H4N2
CrystEngComm (2015) 17, 26 4832
a=14.893(3)Å b=31.878(6)Å c=6.5992(14)Å
α=90° β=95.192(4)° γ=90°
Sinapic Acid + 6-Propyl-2-thiouracil . 2 Acetonitrile
C11H12O5,C7H10N2OS,2(C2H3N)
CrystEngComm (2015) 17, 26 4832
a=8.2922(8)Å b=10.5857(10)Å c=14.7818(15)Å
α=98.274(2)° β=94.315(2)° γ=105.620(2)°
Sinapic Acid + 6-Propyl-2-thiouracil . 2 Acetonitrile
C11H12O5,C7H10N2OS,2(C2H3N)
CrystEngComm (2015) 17, 26 4832
a=8.4520(6)Å b=10.6050(10)Å c=14.9134(13)Å
α=98.535(3)° β=94.470(3)° γ=104.130(3)°
Sinapic Acid
C11H12O5
CrystEngComm (2015) 17, 26 4832
a=4.7531(7)Å b=15.683(2)Å c=14.170(2)Å
α=90° β=90.383(3)° γ=90°
Sinapic Acid + Nicotinamide
C11H12O5,C6H6N2O
CrystEngComm (2015) 17, 26 4832
a=4.9109(11)Å b=9.1732(18)Å c=18.814(4)Å
α=99.563(7)° β=94.601(7)° γ=90.531(7)°
Trans-Methyl-3-(phenylsulfonyl)-1-propylpyrrolidin-2-one
C14H19NO3S
Organic & biomolecular chemistry (2014) 12, 38 7612-7628
a=7.681(3)Å b=12.525(5)Å c=14.693(6)Å
α=90° β=90° γ=90°
BS-II-U-69 2,3,5,6-Me4-pyrazine-1-oxide, urea
C8H12N2O,CH4N2O
Chemical communications (Cambridge, England) (2018) 54, 37 4657-4660
a=12.646(13)Å b=7.002(7)Å c=22.75(2)Å
α=90.00° β=90.00° γ=90.00°
C6H5NO3,CH4N2O
C6H5NO3,CH4N2O
Chemical communications (Cambridge, England) (2018) 54, 37 4657-4660
a=7.2016(19)Å b=26.812(6)Å c=9.497(2)Å
α=90° β=104.392(13)° γ=90°
BS-II-U-5 (urea)2, citric acid
C6H8O7,2(CH4N2O)
Chemical communications (Cambridge, England) (2018) 54, 37 4657-4660
a=6.5395(5)Å b=6.7758(5)Å c=15.2596(11)Å
α=81.525(2)° β=85.861(2)° γ=74.230(2)°
BS-II-U-79 urea, 2,3,5,6-Me4-pyrazine-1,4-dioxide
C8H12N2O2,CH4N2O
Chemical communications (Cambridge, England) (2018) 54, 37 4657-4660
a=11.6812(10)Å b=13.2376(12)Å c=6.9737(6)Å
α=90.00° β=100.298(4)° γ=90.00°
C10H10I2O2,H2O
C10H10I2O2,H2O
New Journal of Chemistry (2018) 42, 13 10539
a=8.5167(5)Å b=8.5167(5)Å c=8.8404(9)Å
α=90° β=90° γ=90°
C12H12N2,C10H12O2
C12H12N2,C10H12O2
New Journal of Chemistry (2018) 42, 13 10539
a=11.5202(15)Å b=7.7849(10)Å c=11.8577(16)Å
α=90° β=114.559(2)° γ=90°
C10H10I2O2
C10H10I2O2
New Journal of Chemistry (2018) 42, 13 10539
a=11.1961(17)Å b=11.5073(18)Å c=9.2386(15)Å
α=90° β=100.613(4)° γ=90°
C10H10I2O2,C12H12N2
C10H10I2O2,C12H12N2
New Journal of Chemistry (2018) 42, 13 10539
a=7.8440(14)Å b=11.568(2)Å c=12.755(2)Å
α=92.124(6)° β=97.154(6)° γ=109.722(6)°
C10H10I2O2,C10H8N2
C10H10I2O2,C10H8N2
New Journal of Chemistry (2018) 42, 13 10539
a=9.5108(4)Å b=10.5838(6)Å c=22.0298(8)Å
α=90° β=100.451(4)° γ=90°
C10H10I2O2,C10H8N2
C10H10I2O2,C10H8N2
New Journal of Chemistry (2018) 42, 13 10539
a=7.7674(8)Å b=10.0010(10)Å c=26.238(3)Å
α=81.2340(10)° β=89.2680(10)° γ=85.8440(10)°
C10H10I2O2,C12H10N2
C10H10I2O2,C12H10N2
New Journal of Chemistry (2018) 42, 13 10539
a=7.8373(7)Å b=11.6273(11)Å c=12.6853(12)Å
α=93.5792(12)° β=96.5739(11)° γ=107.2327(11)°
C10H12O2,C10H8N2
C10H12O2,C10H8N2
New Journal of Chemistry (2018) 42, 13 10539
a=5.9239(5)Å b=12.3895(9)Å c=13.2181(8)Å
α=110.998(6)° β=96.684(6)° γ=99.359(6)°
C11H10IN3O
C11H10IN3O
CrystEngComm (2019) 21, 40 6048
a=26.035(8)Å b=4.7746(16)Å c=9.927(4)Å
α=90° β=99.80(2)° γ=90°
C13H13N3,0.5(C2H2O4)
C13H13N3,0.5(C2H2O4)
CrystEngComm (2019) 21, 40 6048
a=10.478(3)Å b=10.115(3)Å c=13.052(4)Å
α=90° β=106.830(12)° γ=90°
C11H8IN3
C11H8IN3
CrystEngComm (2019) 21, 40 6048
a=4.4460(14)Å b=13.030(4)Å c=19.520(7)Å
α=90° β=90° γ=90°
Mp-p1B-H5 F5-I-benzene, [1,2,3]Triazolo[1,5-a]quinoline
(C6F5I)(C10H7N3)
CrystEngComm (2016) 18, 44 8631
a=7.8304(9)Å b=15.1834(18)Å c=12.9152(15)Å
α=90.00° β=103.176(5)° γ=90.00°
Mp-p1b-Hb7 1,4-diiodotetrafluorobenzene, ([1,2,3]Triazolo[1,5-a]quinoline)2
(C6F4I2)(C10H7N3)2
CrystEngComm (2016) 18, 44 8631
a=6.6906(14)Å b=9.568(2)Å c=10.618(2)Å
α=64.954(6)° β=79.728(5)° γ=87.328(5)°
Mp-p1b-H11 {[1,2,3]Triazolo[1,5-a]quinoline}2, HOOC-(CH2)4-COOH
(C10H7N3)2(C6H10O4)
CrystEngComm (2016) 18, 44 8631
a=6.9843(6)Å b=25.501(2)Å c=6.8129(6)Å
α=90.00° β=108.111(4)° γ=90.00°
Mp-p1b-H21 [1,2,3]Triazolo[1,5-a]quinoline, 2-F-PhCOOH
(C10H7N3)(C7H5O2F)
CrystEngComm (2016) 18, 44 8631
a=6.3976(15)Å b=20.616(5)Å c=10.876(3)Å
α=90.00° β=98.126(9)° γ=90.00°
Mp-p1b-H15 {[1,2,3]Triazolo[1,5-a]quinoline}2, HOOC-(CH2)3-COOH
(C10H7N3)2(C5H8O4)
CrystEngComm (2016) 18, 44 8631
a=28.065(11)Å b=36.966(14)Å c=4.2708(16)Å
α=90.00° β=90.00° γ=90.00°
Mp-p1b-H24 {[1,2,3]Triazolo[1,5-a]quinoline}2, 4-I-F4-PhCOOH
(C10H7N3)2(C7HF4IO2)
CrystEngComm (2016) 18, 44 8631
a=6.6580(8)Å b=9.8155(11)Å c=10.4663(13)Å
α=65.256(4)° β=79.993(4)° γ=84.833(4)°
EK-A-Adp [2-pyridyl-CONH-N=CH-(3-pyridyl)]2, HOOC-(CH2)4-COOH
(C12H10N4O)2(C6H10O4)
CrystEngComm (2017)
a=5.9660(5)Å b=7.2613(6)Å c=16.8960(14)Å
α=89.858(2)° β=80.013(3)° γ=79.638(2)°
EK-A-Pim (2-pyridyl)-CONH-N=CH-(3-pyridyl), HOOC-(CH2)5-COOH
(C12H10N4O)(C7H12O4)
CrystEngComm (2017)
a=5.5981(7)Å b=45.389(5)Å c=7.3036(8)Å
α=90.00° β=98.469(5)° γ=90.00°
EK-D-Sub [(4-pyridyl)-CONH-N=CH-(2-pyridyl)]2, HOOC-(CH2)6-COOH dihydrate
(C12H10N4O)2(C8H14O4)(H2O)2
CrystEngComm (2017)
a=6.6774(11)Å b=8.2196(14)Å c=15.972(3)Å
α=81.888(7)° β=83.771(8)° γ=74.805(7)°
EK-B-Glu (3-pyridyl)-CONH-N=CH-(4-pyridyl), HOOC-(CH2)3-COOH dihydrate
(C12H10N4O)(C5H8O4)(H2O)2
CrystEngComm (2017)
a=10.9929(10)Å b=11.4742(10)Å c=16.1087(14)Å
α=102.095(3)° β=108.567(4)° γ=95.615(3)°
EK-B-Suc 3-pyridyl-CONH-N=CH-(3-pyridyl), HOOC-(CH2)2-COOH
(C12H10N4O)(C4H6O4)(H2O)
CrystEngComm (2017)
a=7.1160(8)Å b=13.0840(16)Å c=36.062(5)Å
α=90.00° β=90.00° γ=90.00°
EK-D-Adp [(4-pyridyl)-CONH-N=CH-(2-pyridyl)]2, HOOC-(CH2)4-COOH dihydrate
(C12H10N4O)2(C6H10O4)(H2O)2
CrystEngComm (2017)
a=6.5986(6)Å b=8.0173(8)Å c=15.3396(14)Å
α=97.862(4)° β=101.861(3)° γ=104.541(3)°
EK-A-Azl (2-pyridyl)-CONH-N=CH-(3-pyridyl), HOOC-(CH2)7-COOH
(C12H10N4O)(C9H16O4)
CrystEngComm (2017)
a=8.5041(12)Å b=9.6723(14)Å c=14.013(2)Å
α=80.742(6)° β=81.368(6)° γ=68.770(5)°
EK-C-Dod (3-pyridyl)-CONH-N=CH-(3-pyridyl), HOOC-(CH2)10-COOH hydrate
(C12H10N4O)(C12H22O4)(H2O)
CrystEngComm (2017)
a=6.9300(8)Å b=7.8773(10)Å c=24.680(3)Å
α=85.562(6)° β=83.394(6)° γ=66.198(5)°
EK-C-Seb (3-pyridyl)-CONH-N=CH-(3-pyridyl), HOOCH-(CH2)8-COOH hydrate
(C12H10N4O)(C10H18O4)(H2O)
CrystEngComm (2017)
a=6.9504(10)Å b=14.170(2)Å c=23.788(3)Å
α=79.555(9)° β=84.610(8)° γ=89.821(9)°
EK-D-Azl [(4-pyridyl)-CONH-N=CH-(2-pyridyl)]2, HOOC-(CH2)7-COOH dihydrate
(C12H10N4O)2(C9H16O4)(H2O)2
CrystEngComm (2017)
a=36.802(8)Å b=7.2815(14)Å c=12.533(3)Å
α=90.00° β=92.978(8)° γ=90.00°
EK-A-Glu (2-pyridyl)-CONH-NHCO-(3-pyridyl), HOOC-(CH2)3-COOH
(C12H10N4O)(C5H8O4)
CrystEngComm (2017)
a=20.694(3)Å b=5.5714(8)Å c=14.954(2)Å
α=90.00° β=105.047(7)° γ=90.00°
EK-A-Mal (2-pyridyl)-CONH-N=CH-(3-pyridyl), HOOC-(CH2)1-COOH
(C12H10N4O)(C3H4O4)
CrystEngComm (2017)
a=8.0953(12)Å b=9.9439(14)Å c=10.1459(15)Å
α=99.924(6)° β=106.674(6)° γ=100.865(6)°
C10H12O2,H2O
C10H12O2,H2O
New Journal of Chemistry (2018) 42, 13 10539
a=9.9472(12)Å b=6.1399(8)Å c=16.775(2)Å
α=90° β=104.248(2)° γ=90°
Mp-p1b-H10 [1,2,3]Triazolo[1,5-a]quinoline
C10H7N3
CrystEngComm (2016) 18, 44 8631
a=10.9465(10)Å b=8.6731(8)Å c=50.527(5)Å
α=90.00° β=93.861(4)° γ=90.00°
Mp-p1b-H29 [1,2,3]Triazolo[1,5-a]pyridine, 1,3,5-F3-2,4,6-I3-benzene
(C6H5N3)(C6F3I3)
CrystEngComm (2016) 18, 44 8631
a=9.3698(6)Å b=13.7351(9)Å c=12.2408(8)Å
α=90.00° β=90.6496(15)° γ=90.00°
Mp-p1b-H28 [1,2,3]triazolo[1,5-a]pyridine, 1,2-diiodotetrafluorobenzene
(C6H5N3)(C6F4I2)
CrystEngComm (2016) 18, 44 8631
a=8.1237(17)Å b=7.1542(15)Å c=12.318(3)Å
α=90° β=92.502(7)° γ=90°
EK-B-Mal (3-pyridyl)-CONH-N=CH-(4-pyridyl), HOOC-(CH2)-COOH
(C12H10N4O)(C3H4O4)
CrystEngComm (2017)
a=7.0290(10)Å b=10.5537(15)Å c=10.8826(15)Å
α=73.431(5)° β=76.424(5)° γ=71.357(5)°
AS-15 2-(4-tolyl)-2,4-pentanedione
C12H14O2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=7.5220(8)Å b=6.6202(7)Å c=11.1582(12)Å
α=90.00° β=108.875(4)° γ=90.00°
AS-14 2-(4-chlorophenyl)-2,4-pentanedione
C11H11ClO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=20.2258(14)Å b=6.7622(5)Å c=7.3688(5)Å
α=90.00° β=90.00° γ=90.00°
AS-5 2-(4-bromophenyl)-2,4-pentanedione
C11H11BrO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=20.4766(18)Å b=6.8070(6)Å c=7.3506(6)Å
α=90.00° β=90.00° γ=90.00°
PC-7-3-Iacac 2-(4-iodophenyl)-2,4-pentanedione
C11H11IO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=21.0708(12)Å b=6.9034(4)Å c=7.3624(4)Å
α=90.00° β=90.00° γ=90.00°
AS-12 2-(4-tolyl)-2,4-pentanedione, copper(II) tetrafluoroborate
(C12H13O2)2Cu
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=11.9427(6)Å b=16.3128(8)Å c=21.4984(11)Å
α=90.00° β=90.00° γ=90.00°
AS-6 bis[2-(4-bromophenyl)-2,4-pentanedionato]copper(II)
(C11H10BrO2)2(Cu)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=12.0389(11)Å b=15.8409(12)Å c=22.1627(17)Å
α=90.00° β=90.00° γ=90.00°
D1 bis[2-(4-chlorophenyl)-2,4-pentanedionato]copper(II)
(C11H10ClO2)2Cu
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=11.9763(7)Å b=15.8265(9)Å c=21.7849(11)Å
α=90.00° β=90.00° γ=90.00°
AS-10 2-(4-iodophenyl)-2,4-pentanedione, copper(II) nitrate
(C11H10IO2)2Cu
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=8.2510(4)Å b=7.7262(4)Å c=17.8085(10)Å
α=90.00° β=101.525(3)° γ=90.00°
KETA 1,3,5-tris-[CH(=NOH)]-benzene
C9H9N3O3
Chem.Commun. (2012) 48, 11289
a=16.6967(11)Å b=4.2787(3)Å c=13.1262(8)Å
α=90.00° β=90.00° γ=90.00°
C12H11N5,0.5(C6F4I2)
C12H11N5,0.5(C6F4I2)
Faraday Discuss. (2017)
a=5.0691(14)Å b=8.055(2)Å c=19.750(5)Å
α=93.952(13)° β=93.442(12)° γ=105.938(16)°
2(C18H15N3O2),C8H14O4
2(C18H15N3O2),C8H14O4
Acta Crystallographica Section B (2018) 74, 1 42-48
a=7.889(4)Å b=9.157(4)Å c=14.832(7)Å
α=86.153(19)° β=83.38(2)° γ=69.517(18)°
2(C18H15N3O2),C4H6O4
2(C18H15N3O2),C4H6O4
Acta Crystallographica Section B (2018) 74, 1 42-48
a=10.145(4)Å b=18.472(7)Å c=9.421(3)Å
α=90° β=91.423(19)° γ=90°
2(C18H15N3O2),C12H22O4
2(C18H15N3O2),C12H22O4
Acta Crystallographica Section B (2018) 74, 1 42-48
a=7.5496(16)Å b=16.434(4)Å c=17.094(4)Å
α=90° β=93.547(12)° γ=90°
C18H16N3O2,Cl
C18H16N3O2,Cl
Acta Crystallographica Section B (2018) 74, 1 42-48
a=9.507(2)Å b=7.9958(17)Å c=43.262(9)Å
α=90° β=90° γ=90°
2(C18H16N3O2),C6H8O4,C6H10O4,CH4O
2(C18H16N3O2),C6H8O4,C6H10O4,CH4O
Acta Crystallographica Section B (2018) 74, 1 42-48
a=9.304(4)Å b=15.756(8)Å c=15.829(7)Å
α=94.54(2)° β=93.95(2)° γ=104.56(2)°
2-methylthiobenzamide & 1,4-diiodotetrafluorobenzene (2:1) cocrystal
C6F4I2,2(C8H9NS)
Crystal Growth & Design (2015) 15, 7 3442
a=8.1916(4)Å b=8.6229(4)Å c=9.6939(5)Å
α=97.9080(10)° β=93.2950(10)° γ=112.0730(10)°
Thiobenzamide & 1,4-diiodotetrafluorobenzene (1:1) cocrystal
C6F4I2,C7H7NS'
Crystal Growth & Design (2015) 15, 7 3442
a=5.774(4)Å b=10.168(8)Å c=13.264(10)Å
α=88.77(2)° β=84.79(2)° γ=82.25(2)°
Thiobenzamide & 1,4-diiodotetrafluorobenzene (2:3) cocrystal
3(C6F4I2),2(C7H7NS
Crystal Growth & Design (2015) 15, 7 3442
a=6.2654(5)Å b=10.9683(10)Å c=15.3237(13)Å
α=80.406(3)° β=81.396(3)° γ=79.248(3)°
3-methylthiobenzamide & 1,4-diiodotetrafluorobenzene (2:1) cocrystal
C6F4I2,2(C8H9NS)
Crystal Growth & Design (2015) 15, 7 3442
a=10.4324(7)Å b=5.4480(3)Å c=21.0125(14)Å
α=90° β=102.340(2)° γ=90°
Alpha form of 4-methylthiobenzamide & 1,4-diiodotetrafluorobenzene (2:1) cocrystal
C6F4I2,2(C8H9NS)
Crystal Growth & Design (2015) 15, 7 3442
a=7.9155(4)Å b=11.2629(6)Å c=15.2608(9)Å
α=69.6170(10)° β=81.5520(10)° γ=76.4080(10)°
Beta form of 4-methylthiobenzamide & 1,4-diiodotetrafluorobenzene (2:1) cocrystal
C6F4I2,2(C8H9NS)
Crystal Growth & Design (2015) 15, 7 3442
a=28.2332(14)Å b=10.7096(6)Å c=8.1690(4)Å
α=90° β=91.1780(10)° γ=90°
4-methoxythiobenzamide & 1,4-diiodotetrafluorobenzene (4:3) cocrystal
3(C6F4I2),4(C8H9NOS)
Crystal Growth & Design (2015) 15, 7 3442
a=5.8460(10)Å b=13.270(2)Å c=20.334(4)Å
α=71.991(4)° β=83.885(4)° γ=79.176(4)°
4-chlorothiobenzamide & 1,4 diiodotetrafluorobenzene (2:1) cocrystal
C6F4I2,2(C7H6ClNS)
Crystal Growth & Design (2015) 15, 7 3442
a=12.0308(17)Å b=9.2912(11)Å c=11.6550(16)Å
α=90° β=107.790(4)° γ=90°
2-methoxythiobenzamide & 1,4-diiodotetrafluorobenzene (2:1) cocrystal
C6F4I2,2(C8H9NOS)
Crystal Growth & Design (2015) 15, 7 3442
a=10.746(3)Å b=6.1830(16)Å c=18.780(5)Å
α=90° β=98.107(7)° γ=90°
3-methoxythiobenzamide & 1,4-diiodotetrafluorobenzene (2:1) cocrystal
C6F4I2,2(C8H9NOS)
Crystal Growth & Design (2015) 15, 7 3442
a=6.7544(8)Å b=9.9221(12)Å c=18.4744(18)Å
α=90° β=93.261(3)° γ=90°
3-nitrothiobenzamide & 1,4-diiodotetrafluorobenzene (4:3) cocrystal
C6F4I2,2(C7H6N2O2S)
Crystal Growth & Design (2015) 15, 7 3442
a=5.1924(7)Å b=14.745(2)Å c=16.356(3)Å
α=90° β=98.258(5)° γ=90°
2-fluorothiobenzamide & 1,4-diiodotetrafluorobenzene (1:1) cocrystal
C6F4I2,C7H6FNS
Crystal Growth & Design (2015) 15, 7 3442
a=6.2828(3)Å b=10.9161(5)Å c=12.9878(6)Å
α=110.5560(10)° β=96.2050(10)° γ=102.9010(10)°
2-chlorothiobenzamide & 1,4 diiodotetrafluorobenzene (4:3) cocrystal
3(C6F4I2),4(C7H6ClNS)
Crystal Growth & Design (2015) 15, 7 3442
a=4.2868(4)Å b=13.6897(13)Å c=25.474(3)Å
α=105.469(2)° β=91.027(2)° γ=96.835(2)°
Pyridine-2-carbothioamide & 1,4 diiodotetrafluorobenzene (2:1) cocrystal
C6F4I2,2(C6H6N2S)
Crystal Growth & Design (2015) 15, 7 3442
a=13.7819(16)Å b=7.0458(8)Å c=11.6222(12)Å
α=90° β=97.938(4)° γ=90°